Emerald Mutual Fund Advisers Trust’s Epizyme, Inc EPZM Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-428,145	Closed	-$8.08M	–	240
2014 Q4	$8.08M	Buy	428,145 +177,467	+71%	+$4.15M	0.7%	54
2014 Q3	$6.8M	Sell	250,678 -1,070	-0.4%	-$33.3K	0.65%	58
2014 Q2	$7.83M	Buy	251,748 +8,910	+4%	+$210K	0.72%	53
2014 Q1	$5.53M	Buy	242,838 +135,448	+126%	+$4.11M	0.53%	73
2013 Q4	$3.3M	Buy	+107,390	New	+$3.11M	0.2%	119
2013 Q3	–	Sell	-68,719	Closed	-$1.93M	–	225
2013 Q2	$1.93M	Buy	+68,719	New	+$1.77M	0.33%	100

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's EPZM Position: Q1 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Epizyme, Inc (EPZM) in Q1 2015, closing a stake of 428,145 shares — an estimated $8.08M sold.

Emerald Mutual Fund Advisers Trust first reported a position in EPZM in Q2 2013 and held it in 6 quarters. The position peaked at $8.08M in Q4 2014. 103 funds tracked by Wall St. Rank hold EPZM as of Q1 2015.

Emerald Mutual Fund Advisers Trust reported no remaining Epizyme, Inc position as of Q1 2015 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 428,145 Epizyme, Inc shares in Q1 2015, an estimated $8.08M.
Emerald Mutual Fund Advisers Trust first reported a position in Epizyme, Inc in Q2 2013 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's Epizyme, Inc position peaked at $8.08M in Q4 2014.
103 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2015, filed 29 Apr 2015.